Comparative analysis of resistant and susceptible macrophage gene expression response to Leishmania major parasite

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Rabhi, Imen ^a   Rabhi, Sameh ^a   Ben Othman, Rym ^a   Aniba, Mohamed R ^b   Trentin, Bernadette ^c   Piquemal, David ^c   Regnault, Béatrice ^d   Guizani Tabbane, Lamia ^a   Attia, Hanène ^e   Ben Miled, Slimane ^e   Benkahla, Alia ^e   Bruno, Roman ^e   Cazenave, Pierre André ^e   Checkmeneva, Elena ^e   Daskalaki, Andriani ^e   Dellagi, Koussay ^e   Gabdoulline, Razif ^e   Ghedira, Kais ^e   Guerfali, Fatma Z ^e   Gustin, Cindy ^e   Herwig, Ralf ^e   Hide, Winston ^e   Hofmann, Oliver ^e   Hornischer, Klaus ^e   Kel, Alexander ^e   Kiselev, Ilya ^e   Kolpakov, Fedor ^e   Kondrakhin, Yuriy ^e   Kutumova, Elena ^e   Land, Sigrid ^e   Laouini, Dhafer ^e   Lemaire, Julien ^e   Liebich, Ines ^e   Manchon, Laurent ^e   Matys, Volker ^e   Michael, Holger ^e   Mkannez, Ghada ^e   Noguier, Florian ^e   Pierrat, Fabien ^e   Rasche, Axel ^e   Renard, Patricia ^e   Ryabova, Anna ^e   Sandoval, Ruy Jauregui ^e   Schacherer, Frank ^e   Sghaier, Rabiaa Manel ^e   Sharipov, R N ^e   Stegmaier, Philip ^e   Tiffin, Nicki ^e   Tolstykh, Nikita ^e   Valeev, Tagir ^e   Voss, Nico ^e   Wierling, Christoph ^e   Yevshin, Ivan ^e   more..

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b Bldg 142   (United States)

^c Skuldtech Cap Delta ZAC Euromedecine II 1682   (France)

^d INSTITUT PASTEUR   (France)

^e NONE

Author keywords

Gene expression; Leishmania; Macrophages; Microarray

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P53; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENETIC DATABASE; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PROMASTIGOTE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; COMPARATIVE STUDY; CYTOLOGY; DNA MICROARRAY; GENETICS; METABOLISM; PARASITOLOGY; PHYSIOLOGY;

ANIMALIA; LEISHMANIA MAJOR; MUS;

ANIMALS; BONE MARROW CELLS; DATABASES, GENETIC; LEISHMANIA MAJOR; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84886942391     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-723     Document Type: Article

References (38)

1. Buates S, Matlashewski G. General suppression of macrophage gene expression during Leishmania donovani infection. J Immunol 2001, 166(5):3416-3422.
2. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, Nutman TB. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 2003, 102(2):672-681. 10.1182/blood-2002-10-3232, 12663451.
3. Rodriguez NE, Chang HK, Wilson ME. Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi. Infect Immun 2004, 72(4):2111-2122. 10.1128/IAI.72.4.2111-2122.2004, 375188, 15039333.
4. Guerfali FZ, Laouini D, Guizani-Tabbane L, Ottones F, Ben-Aissa K, Benkahla A, Manchon L, Piquemal D, Smandi S, Mghirbi O, et al. Simultaneous gene expression profiling in human macrophages infected with Leishmania major parasites using SAGE. BMC Genomics 2008, 9:238. 10.1186/1471-2164-9-238, 2430024, 18495030.
5. Osorio y Fortea J, de La Llave E, Regnault B, Coppee JY, Milon G, Lang T, Prina E. Transcriptional signatures of BALB/c mouse macrophages housing multiplying Leishmania amazonensis amastigotes. BMC Genomics 2009, 10:119. 10.1186/1471-2164-10-119, 2666765, 19302708.
6. Rabhi I, Rabhi S, Ben-Othman R, Rasche A, Consortium S, Daskalaki A, Trentin B, Piquemal D, Regnault B, Descoteaux A, et al. Transcriptomic signature of Leishmania infected mice macrophages: a metabolic point of view. PLoS Negl Trop Dis 2012, 6(8):e1763. 10.1371/journal.pntd.0001763, 3424254, 22928052.
7. Gregory DJ, Sladek R, Olivier M, Matlashewski G. Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect Immun 2008, 76(3):1186-1192. 10.1128/IAI.01320-07, 2258831, 18086813.
8. Tacchini-Cottier F, Zweifel C, Belkaid Y, Mukankundiye C, Vasei M, Launois P, Milon G, Louis JA. An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J Immunol 2000, 165(5):2628-2636.
9. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 2000, 165(2):969-977.
10. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002, 2(11):845-858. 10.1038/nri933, 12415308.
11. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004, 32(Database issue):D277-D280. 308797, 14681412.
12. Moriya Y, Itoh M, Okuda S, Yoshizawa AC, Kanehisa M. KAAS: an automatic genome annotation and pathway reconstruction server. Nucleic Acids Res 2007, 35(Web Server issue):W182-W185. 1933193, 17526522.
13. Smyth GK, Yang YH, Speed T. Statistical issues in cDNA microarray data analysis. Methods Mol Biol 2003, 224:111-136.
14. Edgar R, Barrett T. NCBI GEO standards and services for microarray data. Nat Biotechnol 2006, 24(12):1471-1472. 10.1038/nbt1206-1471, 2270403, 17160034.
15. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011, 39(Database issue):D561-D568. 3013807, 21045058.
16. Ramirez C, Diaz-Toro Y, Tellez J, Castilho TM, Rojas R, Ettinger NA, Tikhonova I, Alexander ND, Valderrama L, Hager J, et al. Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response. PLoS Negl Trop Dis 2012, 6(10):e1866. 10.1371/journal.pntd.0001866, 3493378, 23145196.
17. Teixeira MJ, Teixeira CR, Andrade BB, Barral-Netto M, Barral A. Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol 2006, 22(1):32-40. 10.1016/j.pt.2005.11.010, 16310413.
18. Beil WJ, Meinardus-Hager G, Neugebauer DC, Sorg C. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J Leukoc Biol 1992, 52(2):135-142.
19. Dantas Cangussú S, Carvalho de Souza C, França Campos C, Quercia Vieira L, Crocco Afonso L, Esteves Arantes R-M. Histopathology of Leishmania major infection: revisiting L. major histopathology in the ear dermis infection model. Mem Inst Oswaldo Cruz, Rio de Janeiro 2009, 104(6):918-922.
20. Bhattacharyya S, Ghosh S, Dasgupta B, Mazumder D, Roy S, Majumdar S. Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J Infect Dis 2002, 185(12):1704-1708. 10.1086/340820, 12085314.
21. Balogh EP, Faludi I, Virok DP, Endresz V, Burian K. Chlamydophila pneumoniae induces production of the defensin-like MIG/CXCL9, which has in vitro antichlamydial activity. Int J Med Microbiol 2011, 301(3):252-259. 10.1016/j.ijmm.2010.08.020, 21056004.
22. Barak Y, Juven T, Haffner R, Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J 1993, 12(2):461-468. 413229, 8440237.
23. Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A 2010, 107(16):7455-7460. 10.1073/pnas.1001006107, 2867677, 20378837.
24. Mates JM, Segura JA, Martin-Rufian M, Campos-Sandoval JA, Alonso FJ, Marquez J. Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer. Curr Mol Med 2013, 13(4):514-534. 10.2174/1566524011313040005, 22934847.
25. Goto H, Gomes CM, Corbett CE, Monteiro HP, Gidlund M. Insulin-like growth factor I is a growth-promoting factor for Leishmania promastigotes and amastigotes. Proc Natl Acad Sci U S A 1998, 95(22):13211-13216. 10.1073/pnas.95.22.13211, 23762, 9789067.
26. Gomes CM, Goto H, Ribeiro Da Matta VL, Laurenti MD, Gidlund M, Corbett CE. Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis. Int J Exp Pathol 2000, 81(4):249-255. 2517735, 10971746.
27. Vendrame CM, Carvalho MD, Rios FJ, Manuli ER, Petitto-Assis F, Goto H. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro. Scand J Immunol 2007, 66(2-3):287-296.
28. Araujo AP, Arrais-Silva WW, Giorgio S. Infection by Leishmania amazonensis in mice: a potential model for chronic hypoxia. Acta Histochem 2012, 114(8):797-804. 10.1016/j.acthis.2012.01.007, 22360823.
29. Duvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 2010, 39(2):171-183. 10.1016/j.molcel.2010.06.022, 2946786, 20670887.
30. Jaramillo M, Gomez MA, Larsson O, Shio MT, Topisirovic I, Contreras I, Luxenburg R, Rosenfeld A, Colina R, McMaster RW, et al. Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Cell Host Microbe 2011, 9(4):331-341. 10.1016/j.chom.2011.03.008, 21501832.
31. Zhang XD, Qin ZH, Wang J. The role of p53 in cell metabolism. Acta Pharmacol Sin 2010, 31(9):1208-1212. 10.1038/aps.2010.151, 20729871.
32. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126(1):107-120. 10.1016/j.cell.2006.05.036, 16839880.
33. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004, 64(7):2627-2633. 10.1158/0008-5472.CAN-03-0846, 15059920.
34. Mathupala SP, Ko YH, Pedersen PL. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006, 25(34):4777-4786. 10.1038/sj.onc.1209603, 3385868, 16892090.
35. Denkers EY, Butcher BA. Sabotage and exploitation in macrophages parasitized by intracellular protozoans. Trends Parasitol 2005, 21(1):35-41. 10.1016/j.pt.2004.10.004, 15639739.
36. Gregory DJ, Olivier M. Subversion of host cell signalling by the protozoan parasite Leishmania. Parasitology 2005, 130(Suppl):S27-S35.
37. Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longley BJ, Ruddle NH, McMahon-Pratt D, Flavell RA. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 1996, 4(3):263-273. 10.1016/S1074-7613(00)80434-3, 8624816.
38. Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 2004, 10(5):540-544. 10.1038/nm1045, 15107845.